Biopharma outsourcing to India is growing by leaps and bounds. This chapter discusses the industry’s preparedness from an environment, health, and safety perspective. Foreign entities are coming under closer scrutiny as to whether the products which are manufactured by their overseas partners and subsidiaries are in conformity with environmental, health and safety guidelines. The guidelines are also discussed in detail and their applicability in the Indian scenario is analysed.
health and safety (EHS)
environment management systems